Back to Market Feed

MEPROBAMATE 200 MG TABLET

$4.9340per EA

DEA Schedule CIV

Strength

200 mg/1

Manufacturer

Alembic Pharmaceuticals Inc.

NDC

62332001931

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

Approval Type

Generic (ANDA)

FDA Application

On Market Since

3/31/2016

Price History

1W

0.0%

1M

-1.2%

3M

+24.8%

6M

+24.8%

1Y

+24.8%

3Y

+231.0%

5Y

+231.0%

All

+244.7%

Generic Alternatives

1 alternative • Same active ingredient

MEPROBAMATE 200 MG TABLET

69097097407•Cipla USA Inc.

Related Drugs

Same classification

No related drugs found.